AVEO Oncology
AVEO
#7488
Rank
NZ$0.92 B
Marketcap
NZ$26.73
Share price
0.00%
Change (1 day)
176.12%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -NZ$44.46 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are NZ$94.31 Million. In 2021 the company made an earning of -NZ$95.06 Million a decrease over its 2020 earnings that were of -NZ$63.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -NZ$44.46 Million-53.23%
2021 -NZ$95.06 Million49.9%
2020 -NZ$63.41 Million-479.04%
2019 NZ$16.72 M-276.17%
2018 -NZ$9.5 Million-91.79%
2017 -NZ$0.12 Billion142.38%
2016 -NZ$47.73 Million78.51%
2015 -NZ$26.74 Million-71.55%
2014 -NZ$93.98 Million-50.72%
2013 -NZ$0.2 Billion-4.88%
2012 -NZ$0.21 Billion-426.29%
2011 NZ$61.44 M-159.85%
2010 -NZ$0.11 Billion35.33%
2009 -NZ$75.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
NZ$59.86 B-115,791.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$18.33 B-35,524.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$1.80 B-3,582.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$9.20 B-17,889.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$21.22 B-41,113.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-NZ$4.03 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA